MindBio Therapeutics is a clinical stage drug development company that is pioneering psychedelic microdosing in multiple Phase 2B clinical trials. MB22001 is MindBio's lead candidate drug, a proprietary titratable form of Lysergic Acid Diethylamide (LSD) designed for safe take home microdosing. ...See more
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
11-50 Employees
Year Founded:
2021 (4 years)
Address:
91-97 WILLIAM STREET; LEVEL 4; MELBOURNE , VICTORIA 3000, AU
LOW
spending power
